Search all trials

Find therapies in clinical trials near you – page 6

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Ovarian cancer+4

Not recruiting

InvestigationalNo placebo

Study on Raludotatug Deruxtecan for Patients with Advanced or Metastatic Solid Tumors, Including Gynecological and Genitourinary Cancers

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Raludotatug Deruxtecan

Contact Research Centre

Ovarian cancer+2

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of PF-07104091 Alone or with Fulvestrant, Letrozole, and Palbociclib for Patients with Advanced Breast, Ovarian, or Lung Cancer

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Fulvestrant

Contact Research Centre

Ovarian cancer

Not recruiting

InvestigationalNo placebo

Study on the Effects of XP-DC+TL+KLH in Patients with Ovarian Cancer Undergoing Chemotherapy

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Xp-Dc+Tl+Klh

Contact Research Centre

Ovarian cancer

Not recruiting

Registered drugNo placebo

Study on Doxorubicin Hydrochloride and Trabectedin for Patients with Recurrent Ovarian Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Trabectedin

Contact Research Centre

Ovarian cancer+2

Not recruiting

Registered drugNo placebo

Study of Relacorilant and Nab-Paclitaxel for Patients with Advanced, Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Relacorilant

Contact Research Centre

Ovarian cancer+13

Not recruiting

InvestigationalNo placebo

Study of Fadraciclib in Adults with Advanced Solid Tumors (Including Breast, Colorectal, Endometrial, Ovarian, Biliary Tract, and Liver Cancer) and Lymphoma

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Fadraciclib

Contact Research Centre

Ovarian cancer+2

Not recruiting

Registered drugNo placebo

Study of Nemvaleukin Alfa and Pembrolizumab for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Nemvaleukin Alfa

Contact Research Centre

Ovarian cancer+5

Not recruiting

Registered drugNo placebo

Study of Nivolumab alone or combined with Ipilimumab for patients with advanced solid tumors (breast, gastric, pancreatic, lung, bladder, or ovarian cancer)

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Ipilimumab

Contact Research Centre

Ovarian cancer

Not recruiting

Registered drugNo placebo

Study on the Safety and Tolerability of KAND567 and Carboplatin for Women with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Ovarian cancer+2

Not recruiting

Registered drugNo placebo

Study of Pembrolizumab for Patients with Recurrent, Platinum-Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Ovarian cancer+2

Not recruiting

Registered drugNo placebo

Study on Niraparib and Dostarlimab for Patients with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Not Suitable for Platinum Treatment

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Ovarian cancer

Not recruiting

Registered drugNo placebo

Study of Olaparib, Durvalumab and UV1 combination as maintenance treatment for patients with recurrent ovarian cancer who do not have BRCA mutations

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Alrefimotide

Contact Research Centre

Find therapies in clinical trials near you – page 6

91 trials match your criteria

Ovarian cancer+4

Study on Raludotatug Deruxtecan for Patients with Advanced or Metastatic Solid Tumors, Including Gynecological and Genitourinary Cancers

Ovarian cancer+2

Study on the Safety and Effectiveness of PF-07104091 Alone or with Fulvestrant, Letrozole, and Palbociclib for Patients with Advanced Breast, Ovarian, or Lung Cancer

Ovarian cancer

Study on the Effects of XP-DC+TL+KLH in Patients with Ovarian Cancer Undergoing Chemotherapy

Ovarian cancer

Study on Doxorubicin Hydrochloride and Trabectedin for Patients with Recurrent Ovarian Cancer

Ovarian cancer+2

Study of Relacorilant and Nab-Paclitaxel for Patients with Advanced, Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer

Ovarian cancer+13

Study of Fadraciclib in Adults with Advanced Solid Tumors (Including Breast, Colorectal, Endometrial, Ovarian, Biliary Tract, and Liver Cancer) and Lymphoma

Ovarian cancer+2

Study of Nemvaleukin Alfa and Pembrolizumab for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.

Ovarian cancer+5

Study of Nivolumab alone or combined with Ipilimumab for patients with advanced solid tumors (breast, gastric, pancreatic, lung, bladder, or ovarian cancer)

Ovarian cancer

Study on the Safety and Tolerability of KAND567 and Carboplatin for Women with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Ovarian cancer+2

Study of Pembrolizumab for Patients with Recurrent, Platinum-Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Ovarian cancer+2

Study on Niraparib and Dostarlimab for Patients with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Not Suitable for Platinum Treatment

Ovarian cancer

Study of Olaparib, Durvalumab and UV1 combination as maintenance treatment for patients with recurrent ovarian cancer who do not have BRCA mutations

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.